Show simple item record

dc.contributor.authorDawson, H
dc.contributor.authorSmrke, A
dc.contributor.authorEllery, PM
dc.contributor.authorWilkinson, N
dc.contributor.authorRosenthal, AN
dc.contributor.authorMcVeigh, TP
dc.date.accessioned2022-06-01T11:56:48Z
dc.date.available2022-06-01T11:56:48Z
dc.date.issued2021-09-15
dc.identifier.citationFamilial cancer, 2021
dc.identifier.issn1389-9600
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/5161
dc.identifier.eissn1573-7292
dc.identifier.eissn1573-7292
dc.identifier.doi10.1007/s10689-021-00275-9
dc.identifier.doi10.1007/s10689-021-00275-9
dc.description.abstractPTEN is a tumour suppressor gene involved in regulating cell division. Pathogenic germline variants in PTEN predispose to benign and malignant growths of numerous organs, including of the breast. In the following report, we describe the first documented case of a fibroadenoma developing in ectopic breast tissue of the vulva in a patient with a germline pathogenic variant in PTEN. This highlights the risk of hyperplasia developing in any breast tissue, including rare ectopic sites, particularly in patients with underlying germline variants in cancer susceptibility genes.
dc.formatPrint-Electronic
dc.languageeng
dc.language.isoeng
dc.publisherSPRINGER
dc.rights.urihttp://www.rioxx.net/licenses/all-rights-reserved
dc.titleFibroadenoma in vulval ectopic breast tissue in a patient with PTEN Hamartoma Tumour Syndrome.
dc.typeJournal Article
dcterms.dateAccepted2021-09-08
rioxxterms.versionAM
rioxxterms.versionofrecord10.1007/s10689-021-00275-9
rioxxterms.licenseref.startdate2021-09-15
dc.relation.isPartOfFamilial cancer
pubs.notesNot known
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Genetics and Epidemiology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Genetics and Epidemiology/Cancer Genetics Education & Quality Improvement
pubs.organisational-group/ICR/Primary Group/Royal Marsden Clinical Units
pubs.publication-statusPublished
pubs.embargo.termsNot known
icr.researchteamCancer Genetics Education & Quality Improvement
dc.contributor.icrauthorMcVeigh, Terri


Files in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record